- Home
- MRAM vs NVCT Comparison
MRAM vs NVCT Comparison
Compare MRAM & NVCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MRAM
- NVCT
- Stock Information
- Founded
- MRAM 2008
- NVCT 2020
- Country
- MRAM United States
- NVCT United States
- Employees
- MRAM N/A
- NVCT N/A
- Industry
- MRAM Semiconductors
- NVCT Medicinal Chemicals and Botanical Products
- Sector
- MRAM Technology
- NVCT Health Care
- Exchange
- MRAM Nasdaq
- NVCT Nasdaq
- Market Cap
- MRAM 131.1M
- NVCT 119.4M
- IPO Year
- MRAM 2016
- NVCT 2022
- Fundamental
- Price
- MRAM $5.87
- NVCT $4.95
- Analyst Decision
- MRAM Strong Buy
- NVCT Strong Buy
- Analyst Count
- MRAM 2
- NVCT 1
- Target Price
- MRAM $9.00
- NVCT $21.00
- AVG Volume (30 Days)
- MRAM 122.9K
- NVCT 320.8K
- Earning Date
- MRAM 10-30-2024
- NVCT 11-05-2024
- Dividend Yield
- MRAM N/A
- NVCT N/A
- EPS Growth
- MRAM N/A
- NVCT N/A
- EPS
- MRAM 0.07
- NVCT N/A
- Revenue
- MRAM $53,865,000.00
- NVCT N/A
- Revenue This Year
- MRAM N/A
- NVCT N/A
- Revenue Next Year
- MRAM $7.15
- NVCT N/A
- P/E Ratio
- MRAM $82.31
- NVCT N/A
- Revenue Growth
- MRAM N/A
- NVCT N/A
- 52 Week Low
- MRAM $4.89
- NVCT $4.83
- 52 Week High
- MRAM $9.44
- NVCT $12.10
- Technical
- Relative Strength Index (RSI)
- MRAM 44.39
- NVCT 35.48
- Support Level
- MRAM $5.78
- NVCT $6.00
- Resistance Level
- MRAM $6.23
- NVCT $11.80
- Average True Range (ATR)
- MRAM 0.27
- NVCT 1.23
- MACD
- MRAM -0.05
- NVCT -0.27
- Stochastic Oscillator
- MRAM 9.60
- NVCT 1.72
About MRAM Everspin Technologies Inc.
Everspin Technologies Inc is a provider of Magnetoresistive Random Access Memory (MRAM) products. Its portfolio of MRAM technologies, including Toggle MRAM and Spin-transfer Torque MRAM (STT-MRAM), delivers superior performance, persistence, and reliability in non-volatile memories that transform how mission-critical data is protected against power loss. The company derives revenue from the sale of MRAM-based products in discrete unit form, licenses of and royalties on MRAM and magnetic sensor technology, the sale of backend foundry services, and design services to third parties. It recognizes revenue in three primary geographic regions; North America; Europe, the Middle East, and Africa (EMEA); and Asia-Pacific (APAC).
About NVCT Nuvectis Pharma Inc.
Nuvectis Pharma Inc is a biopharmaceutical company. The company is engaged in the development of innovative precision medicines for the treatment of serious conditions of unmet medical needs in oncology. It operates with one segment, focused on the development of novel targeted small molecule therapeutics for the treatment of cancer in genetically defined patient populations. Its pipeline products include NXP800, NXP900.